Unranked

Cronos Group Inc.

CRON

$2.835

+1.25% (24h)

Last updated: 1 second ago

Market Cap

$1.06B

Volume (24h)

505.2K

Last Close (7D)

$2.84

View on TradingView

Price Chart

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

610

Website

thecronosgroup.com

Country

🇨🇦 Canada

A Canadian LP majority-backed by Altria (parent of Marlboro), Cronos is a capital-light brand play targeting premium cannabis wellness and lifestyle consumers worldwide.

🚬 Altria's 45%+ stake gives Cronos the financial muscle and distribution know-how of a tobacco giant

Key Stats

52-Week Range

$1.84$3.43

Beta1.25

Trailing P/EInfinity

Forward P/E-70.88

Trailing EPS0.00

Avg Volume1.49M

Enterprise Value$275.86M

Shares Outstanding373.66M

Earnings & Analyst

Next Earnings2026-08-06

EPS EstimateN/A

Target Mean Price$2.46

RecommendationNone

Recommendation MeanN/A

Latest News

Benzinga · May 29, 2026
"Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment
SeekingAlpha · May 14, 2026
Cronos: Strong Q1 Earnings Driven By International Cannabis Sales
SeekingAlpha · May 13, 2026
Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade)
SeekingAlpha · May 11, 2026
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
Benzinga · May 11, 2026
Cronos Announces $50M Buyback Plan
Benzinga · May 11, 2026
Cronos Group Q1 EPS $0.04 Beats $0.01 Estimate, Sales $45.210M Beat $42.200M Estimate